The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy
2003

Effectiveness of Clindamycin for Treating Bacterial Vaginosis in Pregnant Women

Sample size: 404 publication Evidence: high

Author Information

Author(s): Ronald F. Lamont, Brian M. Jones, Debashis Mandal, Philip E. Hay, Marie Sheehan

Primary Institution: Northwick Park and St Mark's NHS Trust

Hypothesis

Is vaginal clindamycin effective in treating bacterial vaginosis during pregnancy?

Conclusion

A 3-day course of clindamycin vaginal cream is more effective than placebo for treating bacterial vaginosis in pregnant women.

Supporting Evidence

  • 18% of women treated with clindamycin were cured compared to 1.6% with placebo.
  • 70.8% of clindamycin patients showed improvement compared to 12% with placebo.
  • 44.8% of clindamycin patients were cured using three diagnostic criteria.

Takeaway

This study shows that a short treatment with clindamycin cream helps pregnant women with a common infection called bacterial vaginosis.

Methodology

A randomized, double-blind, placebo-controlled study involving 404 pregnant women with bacterial vaginosis.

Limitations

The study only included women aged 16 to 40 and may not be generalizable to other populations.

Participant Demographics

Women aged 16 to 40 years, with a live fetus between 13 and 20 weeks gestation.

Statistical Information

P-Value

p < 0.0001

Statistical Significance

p < 0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication